Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.

The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.

Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE).

2026 guidance assumes 10% to 11% growth in U.S. pump shipments, though revenue growth will be moderated by a $70 million to $80 million pricing headwind from the PayGo transition. Management expects ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and thank you ...

In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

For the full year, Tandem reported $1.015 billion in worldwide sales and over 126,000 pump shipments.

Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.

Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and ...

Wareable's extensive review of the Polar Loop (Gen 2), including real-world testing of the design, tracking accuracy, and ...

Square Enix has revealed that NieR: Automata has reached 10 million shipments and digital sales. Plus, it has teased that NieR Automata ‘to be continued…’ Capcom has released Monster Hunter Wilds ...